Structure-switchable aptamer-arranged reconfigurable DNA nanonetworks for targeted cancer therapy

Nanomedicine. 2022 Jul:43:102553. doi: 10.1016/j.nano.2022.102553. Epub 2022 Mar 23.

Abstract

The structural DNA nanotechnology holds great potential application in bioimaging, drug delivery and cancer therapy. Herein, an intelligent aptamer-incorporated DNA nanonetwork (Apt-Nnes) is demonstrated for cancer cell imaging and targeted drug delivery, which essentially is a micron-scale pattern with the thickness of double-stranded monolayer. Cancer cell-surface receptors can make it perform magical transformation into small size of nanosheet intermediates and specifically enter target cells. The binding affinity of Apt-Nnes is increased by 3-fold due to multivalent binding effect of aptamers and it can maintain the structural integrity in fetal bovine serum (FBS) for 8 h. More interestingly, target cancer cells can cause the structural disassembly, and each resulting unit transports 4963 doxorubicin (Dox) into target cells, causing the specific cellular cytotoxicity. The cell surface receptor-mediated disassembly of large size of DNA nanostructures into small size of fractions provides a valuable insight into developing intelligent DNA nanostructure suitable for biomedical applications.

Keywords: DNA nano-networks; Drug delivery; Multivalent aptamers; Targeted cancer therapy.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aptamers, Nucleotide* / chemistry
  • Cell Line, Tumor
  • DNA / chemistry
  • Doxorubicin
  • Drug Delivery Systems / methods
  • Neoplasms* / drug therapy

Substances

  • Aptamers, Nucleotide
  • Doxorubicin
  • DNA